Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07262476 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Jun 2027 to Jan 31, 2029
    • Study completion date: Dec 2027 to Jan 31, 2030
    • Start date changed from estimate of Jan 2026 to Jan 9, 2026
    • Site details revised
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.
Trial Details
NCT Number NCT07262476
Lead Sponsor Minghui Pharmaceutical (Hangzhou) Ltd
Conditions
(from sponsor)		 Thyroid Eye Disease (TED)
Related terms Graves Ophthalmopathy
Enrollment 258 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov